Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TKPHF) Total Current Liabilities (2017 - 2025)

Historic Total Current Liabilities for Takeda Pharmaceutical (TKPHF) over the last 9 years, with Q4 2025 value amounting to $17.0 billion.

  • Takeda Pharmaceutical's Total Current Liabilities rose 2288.4% to $17.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $17.0 billion, marking a year-over-year increase of 2288.4%. This contributed to the annual value of $16.5 billion for FY2025, which is 259.11% up from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Total Current Liabilities of $17.0 billion as of Q4 2025, which was up 2288.4% from $14.5 billion recorded in Q3 2025.
  • Takeda Pharmaceutical's 5-year Total Current Liabilities high stood at $18.8 billion for Q1 2023, and its period low was $13.8 billion during Q4 2024.
  • Over the past 5 years, Takeda Pharmaceutical's median Total Current Liabilities value was $16.2 billion (recorded in 2023), while the average stood at $16.4 billion.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first plummeted by 1745.88% in 2021, then skyrocketed by 2288.4% in 2025.
  • Over the past 5 years, Takeda Pharmaceutical's Total Current Liabilities (Quarter) stood at $15.9 billion in 2021, then decreased by 0.53% to $15.8 billion in 2022, then fell by 2.49% to $15.4 billion in 2023, then decreased by 10.62% to $13.8 billion in 2024, then rose by 22.88% to $17.0 billion in 2025.
  • Its Total Current Liabilities stands at $17.0 billion for Q4 2025, versus $14.5 billion for Q3 2025 and $15.0 billion for Q2 2025.